Neuroscience
Neuroscience(神经科学)
Neuroscience
Neurons communicate with each other, effector organs and sensory organs through the neurotransmitter – receptor pathway at synapses. Neurotransmitters can be divided into 4 major groups: 1. Amino acids (glumate, aspartate, serine, glycine and GABA); 2. Monoamines (norepinephrine, epinephrine, dopamine, histamine, and serotonin); 3. Peptides (opioid peptides, substance P, somatostatin); and 4. Others (acetylcholine, NO, nucleosides). read more
- 5-HT Receptor(442)
- AChR(58)
- AChE(103)
- Alzheimer(115)
- Amyloid β(131)
- BACE(5)
- CGRP (34)
- COX(302)
- DAPK(7)
- Dopamine Receptor(312)
- GABA Receptor(168)
- Gap Junction(18)
- GluR(121)
- Histamine(3)
- Histamine Receptor(243)
- mPEGS-1(4)
- Muscarinic Receptor(43)
- Neuroscience Peptides(48)
- Nicotinic Receptor(66)
- P2 Receptor(2)
- P2X7 receptor(4)
- SSRIs(8)
- Substance P/NK1 Receptor(22)
- NMDA(2)
- Beta-secretase(25)
- CaMK(33)
- Dopamine Transporter(20)
- Monoamine Oxidase(91)
- Serotonin Transporter(57)
- nAChR(103)
- iGluR(163)
- Neurokinin Receptor(75)
- MCHR1 (GPR24)(16)
- mAChR(185)
- GPR139(4)
- Cholecystokinin Receptor(25)
- Behavioral Neuroscience(372)
- DREADD(1)
- Huntington(17)
- Neuroendocrinology(65)
- Neuroprotection(128)
- Ophthalmology(168)
- Pain Research(241)
- Parkinson(78)
- Prion(7)
- Seizure Disorders(99)
- Cholinesterases(13)
- AAK1
- Huntingtin
- α-synuclein
- Transthyretin (TTR)
- Tau Protein(4)
- Neurodegenerative Disorders(7)
- Cholinesterase (ChE)(4)
- Amyloid-β(9)
- γ-secretase(1)
- Ischemia(3)
Neuroscience 相关产品(3932)
- GC46935Bobcat 339CAS: 2280037-51-4纯度: >98.00%
Bobcat 339是一种具有良好选择性的新型胞嘧啶类TET酶抑制剂,对TET1和TET2的IC 50 值分别为33μM和73μM,但不抑制DNA甲基转移酶DNMT3a。
- GC46946BPC 157 (acetate)CAS: 1628202-19-6纯度: >95.00%
A pentadecapeptide with diverse biological activities
- GC46948Brexpiprazole-d8CAS: 1427049-21-5纯度: >99.00%
An internal standard for the quantification of brexpiprazole
- GC46951Bromfenac-d4 (sodium salt)CAS: 2749400-35-7纯度: >99.00%
A neuropeptide with diverse biological activities
- GC46959Bupivacaine-d9CAS: 474668-57-0纯度: >99.00%
An internal standard for the quantification of bupivacaine
- GC46977C16 Ganglioside GM1-d9 (d18:1/16:0-d9) (ammonium salt)CAS: 2750534-76-8纯度: >99.00%
A neuropeptide with diverse biological activities
- GC46978C16 Ganglioside GM2-d9 (d18:1/16:0-d9) (ammonium salt)CAS: 2750534-90-6纯度: >99.00%
An internal standard for the quantification of C16 ganglioside G M2
- GC46981C16 Glucosylceramide-d3 (d18:1/16:0-d3)纯度: >99.00%
A neuropeptide with diverse biological activities
- GC46990C18 Galactosylceramide-d35 (d18:1/18:0-d35)CAS: 145176-92-7纯度: >99.00%
An internal standard for the quantification of C18 galactosylceramide
- GC46992C18 Ganglioside GM1-d3 (d18:1/18:0-d3) (ammonium salt)纯度: >99.00%
A neuropeptide with diverse biological activities
- GC46998C22 Galactosylceramide-d4 (d18:1/22:0-d4)纯度: >99.00%
A neuropeptide with diverse biological activities
- GC46999C22 Glucosylceramide-d4 (d18:1/22:0-d4)CAS: 2738376-81-1纯度: >99.00%
A neuropeptide with diverse biological activities
- GC47008C26 Sphingomyelin-d4 (d18:1/26:0-d4)纯度: >99.00%
A neuropeptide with diverse biological activities
- GC47070Celecoxib-d7CAS: 544686-21-7纯度: >99.00%
An internal standard for the quantification of celecoxib
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC46930 | Bilaid C | 2393866-13-0 | >95.00% | |
A tetrapeptide ?-opioid receptor agonist | ||||
| GC46935 | Bobcat 339 | 2280037-51-4 | >98.00% | |
Bobcat 339是一种具有良好选择性的新型胞嘧啶类TET酶抑制剂,对TET1和TET2的IC 50 值分别为33μM和73μM,但不抑制DNA甲基转移酶DNMT3a。 | ||||
| GC46941 | Bombesin (trifluoroacetate salt) | - | >95.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46946 | BPC 157 (acetate) | 1628202-19-6 | >95.00% | |
A pentadecapeptide with diverse biological activities | ||||
| GC46948 | Brexpiprazole-d8 | 1427049-21-5 | >99.00% | |
An internal standard for the quantification of brexpiprazole | ||||
| GC46951 | Bromfenac-d4 (sodium salt) | 2749400-35-7 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46954 | Bromocriptine-13C-d3 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46959 | Bupivacaine-d9 | 474668-57-0 | >99.00% | |
An internal standard for the quantification of bupivacaine | ||||
| GC46977 | C16 Ganglioside GM1-d9 (d18:1/16:0-d9) (ammonium salt) | 2750534-76-8 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46978 | C16 Ganglioside GM2-d9 (d18:1/16:0-d9) (ammonium salt) | 2750534-90-6 | >99.00% | |
An internal standard for the quantification of C16 ganglioside G M2 | ||||
| GC46981 | C16 Glucosylceramide-d3 (d18:1/16:0-d3) | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46990 | C18 Galactosylceramide-d35 (d18:1/18:0-d35) | 145176-92-7 | >99.00% | |
An internal standard for the quantification of C18 galactosylceramide | ||||
| GC46992 | C18 Ganglioside GM1-d3 (d18:1/18:0-d3) (ammonium salt) | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46997 | C22 Galactosylceramide (d18:1/22:0) | 74645-25-3 | >98.00% | |
A sphingolipid | ||||
| GC46998 | C22 Galactosylceramide-d4 (d18:1/22:0-d4) | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46999 | C22 Glucosylceramide-d4 (d18:1/22:0-d4) | 2738376-81-1 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47007 | C26 Sphingomyelin (d18:1/26:0) | 221097-57-0 | >98.00% | |
A sphingolipid | ||||
| GC47008 | C26 Sphingomyelin-d4 (d18:1/26:0-d4) | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47016 | Cabergoline-d6 | 2738376-76-4 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47053 | CAY10746 | 2247240-76-0 | >95.00% | |
A ROCK1 and ROCK2 inhibitor | ||||
| GC47054 | CAY10748 | 2412902-55-5 | >98.00% | |
A STING agonist | ||||
| GC47058 | CAY10756 | 2411382-24-4 | >99.50% | |
An inhibitor of ASK1 | ||||
| GC47060 | CAY10762 | 2514-37-6 | >95.00% | |
An inhibitor of MAGL | ||||
| GC47070 | Celecoxib-d7 | 544686-21-7 | >99.00% | |
An internal standard for the quantification of celecoxib | ||||
